Arrhythmic Storm

1

Review clinical trials related to Arrhythmic Storm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

In-hospital Stellate Ganglion Block for Arrhythmic Storm

Arrhythmic storm is a real emergency and its treatment could be challenging. Antiarrhythmic drugs are few and often ineffective. Neuromodulation has been grown in evidences but no large multicentric studies are present in literature about safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB). Patients with an electrical storm refractory to at least one antiarrhythmic drug will receive PSGB and will be enrolled in the present study. The number of defibrillations before and after the treatment will be compared, complications will be annotated.

Participants needed: 500
Trial details
Biological sex: AllType: ObservationalSponsor: Fondazione IRCCS Policlinico San Matteo di PaviaUpdated: Jun 8, 2025Locations: 38Duration: 1 Day
Eligibility criteria

age ≥ 18 years, [+1]

A previous history of cardiac sympathicectomy [+3]